help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funaba, M.
Right arrow Articles by Mathews, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funaba, M.
Right arrow Articles by Mathews, L. S.
Molecular Endocrinology 14 (10): 1583-1591
Copyright © 2000 by The Endocrine Society

Identification and Characterization of Constitutively Active Smad2 Mutants: Evaluation of Formation of Smad Complex and Subcellular Distribution

Masayuki Funaba and Lawrence S. Mathews

Department of Biological Chemistry University of Michigan Ann Arbor, Michigan 48109-0606

Smads mediate activin, transforming growth factor ß (TGFß), and bone morphogenetic protein signaling from receptors to nuclei. According to the current model, activated activin/TGFß receptors phosphorylate the carboxyl-terminal serines of Smad2 and Smad3 (SSMS-COOH); phosphorylated Smad2/3 oligomerizes with Smad4, translocates to the nucleus, and modulates transcription of defined genes. To test key features of this model in detail, we explored the construction of constitutively active Smad2 mutants. To mimic phosphorylated Smad2, we made two Smad2 mutants with acidic amino acid substitutions of carboxyl-terminal serines: Smad2–2E (Ser465, 467Glu) and Smad2–3E (Ser464, 465, 467Glu). The mutants enhanced basal transcriptional activity in a mink lung epithelial cell line, L17. In a Smad4-deficient cell line, SW480.7, Smad2–2E did not affect basal signaling; however, cotransfection with full-length Smad4, but not transfection of Smad4 alone, resulted in enhanced basal transcriptional activity, suggesting that the constitutively active Smad2 mutant also requires Smad4 for function. In vitro protein interaction analysis revealed that Smad2–2E bound more tightly to Smad4 than did wild-type Smad2; dissociation constants were 270 ± 66 nM for wild-type Smad2:Smad4 complexes and 79 ± 18 nM for Smad2–2E:Smad4 complexes. Determination of the subcellular localization of Smad2 revealed that a greater percentage of Smad2–2E was localized in the nucleus than wild-type Smad2. These results suggest that Smad2 phosphorylation results in both tighter binding to Smad4 and increased nuclear concentration; those changes may be responsible for transcriptional activation by Smad2.




This article has been cited by other articles:


Home page
J. Cell Biol.Home page
T. Morita, T. Mayanagi, and K. Sobue
Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling
J. Cell Biol., December 3, 2007; 179(5): 1027 - 1042.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
J.-P. Liu
The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord
Development, August 1, 2006; 133(15): 2865 - 2874.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Finotto, M. Hausding, A. Doganci, J. H. Maxeiner, H. A. Lehr, C. Luft, P. R. Galle, and L. H. Glimcher
Asthmatic changes in mice lacking T-bet are mediated by IL-13
Int. Immunol., August 1, 2005; 17(8): 993 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Funaba, T. Ikeda, M. Murakami, K. Ogawa, K. Tsuchida, H. Sugino, and M. Abe
Transcriptional Activation of Mouse Mast Cell Protease-7 by Activin and Transforming Growth Factor-{beta} Is Inhibited by Microphthalmia-associated Transcription Factor
J. Biol. Chem., December 26, 2003; 278(52): 52032 - 52041.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Mukasa, M. Nomura, T. Tanaka, K. Tanaka, Y. Nishi, T. Okabe, K. Goto, T. Yanase, and H. Nawata
Activin Signaling through Type IB Activin Receptor Stimulates Aromatase Activity in the Ovarian Granulosa Cell-Like Human Granulosa (KGN) Cells
Endocrinology, April 1, 2003; 144(4): 1603 - 1611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Funaba, C. M. Zimmerman, and L. S. Mathews
Modulation of Smad2-mediated Signaling by Extracellular Signal-regulated Kinase
J. Biol. Chem., October 25, 2002; 277(44): 41361 - 41368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-W. Wu, R. Fairman, J. Penry, and Y. Shi
Formation of a Stable Heterodimer between Smad2 and Smad4
J. Biol. Chem., June 1, 2001; 276(23): 20688 - 20694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society